WAFERGEN BIO-SYSTEMS, INC. FREMONT, Calif., May 03, 2016 (GLOBE NEWSWIRE) -- WaferGen Bio-systems, Inc. (NASDAQ:WGBS), a life sciences tools company focused on developing and commercializing technology platforms for genomics solutions, announced today that it will report financial results for the first quarter ended March 31, 2016 after the market close, and host a conference call and webcast on Tuesday, May 10, 2016.
| Conference Call & Webcast | ||||||
| Tuesday, May 10 at 5:00 PM Eastern Time: | ||||||
| Domestic: | 877-407-3982 | |||||
| International: | 201-493-6780 | |||||
| Conference ID: | 13635406 | |||||
| Webcast: | http://public.viavid.com/index.php?id=119193 | |||||
| Replays, available through May 24: | ||||||
| Toll-Free: | 877-870-5176 | |||||
| International: | 858-384-5517 | |||||
| Conference ID: | 13635406 | |||||
About WaferGen
WaferGen Bio-systems, Inc. is a biotechnology company that offers innovative genomic technology solutions for single-cell analysis and clinical research. The single cell analysis platform is a revolutionary system which can isolate thousands of single cells and processes specific cells for analysis, including Next Generation Sequencing (NGS). The SmartChip platform can be used for profiling and validating molecular biomarkers, and can perform massively-parallel single-plex PCR for one-step target enrichment and library preparation for clinical NGS. These technologies offer a powerful set of tools for biological analysis at the molecular and single-cell level in the life sciences, pharmaceutical, and clinical laboratory industries.
INVESTOR CONTACTS: LifeSci Advisors, LLC Brian Ritchie BRitchie@LifeSciAdvisors.com WaferGen Bio-systems, Inc. Rollie Carlson Rollie.Carlson@wafergen.com
